GlaxoSmithKline plc (ADR) (GSK)
- NYSE: GSK
- Mkt.Cap.:101.52B
Focused:
Healthcare > Biopharmaceuticals (^BPHRM)
Healthcare > Biopharmaceuticals (^BPHRM) Classification
| Sector | |
|---|---|
Healthcare |
|
Biopharmaceuticals |
|

- - Focused

- - Sector Pure-Play
Sector companies
Top 5 competitive companies in Biopharmaceuticals (^BPHRM) :
| Ticker | Name | Mkt.Cap. |
|---|---|---|
| PFE | Pfizer Inc. | 133.11B |
| NVS | Novartis AG (ADR) | 122.38B |
| RHHBY | Roche Holding Ltd. (ADR) | 121.62B |
| MRK | Merck & Co., Inc. | 110.07B |
| SNY | Sanofi-Aventis SA (ADR) | 78.96B |
Relationships
Sample 8 relationships grouped by relationhip type.
| Ticker | Name | |
|---|---|---|
| Competitors | ||
![]() | ABT | Abbott Laboratories |
![]() | AMGN | Amgen, Inc. |
| Customers | ||
![]() | Government - United States | |
![]() | AGN | Allergan, Inc. |
| Suppliers | ||
![]() | GILD | Gilead Sciences, Inc. |
![]() | Santaris Pharma A/S | |
| Partners | ||
![]() | GILD | Gilead Sciences, Inc. |
![]() | VRX | Valeant Pharmaceuticals International |

- - Defined by the Company

- - Defined by Others
Products & Services
Sample products & services from Biopharmaceuticals (^BPHRM) :
- 159797 (Long-Acting Beta 2 Agonist)
- 159802 (Long-Acting Beta2 Agonist)
- 163090 (5HT-1 Antagonist)
Relative Performance (1Y)
- GlaxoSmithKline plc (ADR) (GSK)
- S&P 500 INDEX (SPX)
- Healthcare > Biopharmaceuticals (^BPHRM)
Subscribe to an RSS Feed Research Reports
- FDA Approval Decisions Report for Apr, 2007 Revere - Apr 01, 2007 - PDF - View Report »
- FDA Approval Decisions Report for Apr, 2008 Revere - Apr 01, 2008 - PDF - View Report »
- FDA Approval Decisions Report for Apr, 2009 Revere - Apr 01, 2009 - PDF - $125.00 - Add to Cart »
- FDA Approval Decisions Report for Aug, 2006 Revere - Aug 01, 2006 - PDF - View Report »
- FDA Approval Decisions Report for Aug, 2007 Revere - Aug 01, 2007 - PDF - View Report »
Healthcare
Biopharmaceuticals